Beijing Konruns Pharmaceutical Co.,Ltd.

SHSE:603590 Lagerbericht

Marktkapitalisierung: CN¥3.8b

Beijing Konruns PharmaceuticalLtd Zukünftiges Wachstum

Future Kriterienprüfungen 5/6

Beijing Konruns PharmaceuticalLtd is forecast to grow earnings and revenue by 34.3% and 24.1% per annum respectively. EPS is expected to grow by 33.9% per annum. Return on equity is forecast to be 7.9% in 3 years.

Wichtige Informationen

34.3%

Wachstumsrate der Gewinne

33.9%

EPS-Wachstumsrate

Pharmaceuticals Gewinnwachstum19.3%
Wachstumsrate der Einnahmen24.1%
Zukünftige Eigenkapitalrendite7.9%
Analystenabdeckung

Low

Zuletzt aktualisiert14 Jun 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Keine Aktualisierungen

Recent updates

Beijing Konruns Pharmaceutical Co.,Ltd.'s (SHSE:603590) Shares Not Telling The Full Story

Sep 29
Beijing Konruns Pharmaceutical Co.,Ltd.'s (SHSE:603590) Shares Not Telling The Full Story

Concerns Surrounding Beijing Konruns PharmaceuticalLtd's (SHSE:603590) Performance

Sep 03
Concerns Surrounding Beijing Konruns PharmaceuticalLtd's (SHSE:603590) Performance

Gewinn- und Umsatzwachstumsprognosen

SHSE:603590 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (CNY Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20261,556295N/A4022
12/31/20251,283235N/A3392
12/31/20241,077186N/A3202
9/30/202484611549165N/A
6/30/2024874137132238N/A
3/31/2024954166126229N/A
12/31/202392015098199N/A
9/30/202399914667134N/A
6/30/20239461125197N/A
3/31/202387681-1077N/A
12/31/202286710123120N/A
9/30/202280111461201N/A
6/30/2022726130-38152N/A
3/31/2022755130-9682N/A
12/31/2021810148-10856N/A
9/30/2021855179-141-20N/A
6/30/2021916180-141-54N/A
3/31/2021949216-2428N/A
12/31/2020809183858N/A
9/30/202085520483119N/A
6/30/2020870220186208N/A
3/31/2020944249238255N/A
12/31/20191,066266243262N/A
9/30/20191,038311266285N/A
6/30/20191,029313303317N/A
3/31/2019982273308327N/A
12/31/2018973264246263N/A
9/30/2018897215250273N/A
12/31/2017591479N/A270N/A
12/31/2016346192N/A148N/A
12/31/2015436195N/A192N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: 603590's forecast earnings growth (34.3% per year) is above the savings rate (2.9%).

Ertrag vs. Markt: 603590's earnings (34.3% per year) are forecast to grow faster than the CN market (25.8% per year).

Hohe Wachstumserträge: 603590's earnings are expected to grow significantly over the next 3 years.

Einnahmen vs. Markt: 603590's revenue (24.1% per year) is forecast to grow faster than the CN market (14% per year).

Hohe Wachstumseinnahmen: 603590's revenue (24.1% per year) is forecast to grow faster than 20% per year.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: 603590's Return on Equity is forecast to be low in 3 years time (7.9%).

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y